MarketBeat
29 Oct 2026, 03:05 UTC · 1h ago
GE HealthCare Technologies Q3 Earnings Call Highlights
Impact · against what's priced in
GEHC is a positive catalyst as the company demonstrates a recovery in the Patient Care Solutions (PCS) segment and raises EPS guidance, both of which the market had previously discounted. While radiopharmaceutical growth is already partially factored in, the operational turnaround in PCS directly addresses the primary drag on the current valuation.
- GEHC+0.40
Challenges what's priced in
- The price assumes
A recovery in the PCS segment from its current decline back to growth
The market is not paying for a PCS recovery, but the segment reported 8.8% organic revenue growth this quarter, driven by improved fulfillment in monitoring and maternal-infant care.
What GEHC's price assumes · Sep 23
